Home Overview Press Room Blog Publications For Students about us
Search

About Other Countries' Policies & Human Biotechnology


The United Kingdom

Countries differ widely in the types of human biotechnologies they regulate, the jurisdiction of authority, the nature of enforcement, and other particulars. One requirement for effective policy is a government agency responsible for licensing and monitoring research and commercial facilities that work with human embryos. Frequently cited models are Canada's Assisted Human Reproduction Act and the United Kingdom’s Human Fertilization and Embryology Authority (HFEA).

Many countries have considered prohibiting the most troubling applications: human reproductive cloning and inheritable genetic modification. To date, they are illegal in nearly 50 countries. Similar legislation is pending in other nations.



International Surrogacy, Global Consumerism, Harms to Women and Childrenby Carmel Shalev, Biopolitical Times guest contributorSeptember 15th, 2014Medical associations, nations, and the international community must intervene in the unregulated global market for surrogacy to protect, promote and sanction the human dignity and human rights of women and children.
Next-Generation Stem Cells Cleared for Human Trialby David CyranoskiNatureSeptember 10th, 2014A Japanese patient with a debilitating eye disease is about to become the first person to be treated with induced pluripotent stem cells.
Genetic Rights and Wrongsby EditorialNatureSeptember 9th, 2014Australia’s decision to uphold a patent on biological material is in danger of hampering the development of diagnostic tests.
Surrogate Targeted After Backing OutBangkok PostSeptember 9th, 2014A Thai surrogate mother who had second thoughts appealed for help from authorities after becoming the target of threats and intimidation by the surrogacy clinic and police working for them.
1 in 27 Babies Conceived Using IVF in 2012The Yomiuri ShimbunSeptember 9th, 2014There has been a sharp increase from 10 years ago in the number of babies in Japan conceived by in vitro fertilization, according to the Japan Society of Obstetrics and Gynecology.
Australian Federal Court Rules Isolated Genetic Material can be PatentedThe GuardianSeptember 4th, 2014The decision is likened to ‘being allowed to patent oxygen’, as critics warn of serious repercussions for medical research.
An International Agreement on Commercial Surrogacy? by Marcy DarnovskyBiopolitical TimesSeptember 4th, 2014A three-day convening in The Hague brought together scholars, women’s health and human rights advocates, and policymakers from 27 countries to tackle concerns about international commercial surrogacy.
Where is the brain in the Human Brain Project?by Yves Frégnac & Gilles LaurentNatureSeptember 3rd, 2014Europe's €1-billion science and technology project needs to clarify its goals and establish transparent governance.
Monument Seeks to End Silence on Killings of the Disabled by the Nazisby Melissa EddyThe New York TimesSeptember 2nd, 2014Among the last to have their suffering publicly acknowledged, the mentally ill and intellectually disabled victims of direct medical killings by the Nazis now have their own memorial in the heart of Berlin.
Australian Father of Thai Surrogate Twins Charged with Sexually Abusing ThemThe TelegraphSeptember 2nd, 2014Thailand's surrogacy industry has been thrown into fresh turmoil - following the case of abandoned Down's syndrome baby Gammy - with a separate incident of abuse.
Displaying 1-10 of 569  
Next >> 
Last Page » 
« Show Complete List » 


ESPAÑOL | PORTUGUÊS | Русский

home | overview | blog | publications| about us | donate | newsletter | press room | privacy policy

CGS • 1936 University Ave, Suite 350, Berkeley, CA 94704 • • (p) 1.510.665.7760 • (F) 1.510.665.8760